Increasing access to needle-and-syringe programs in Canadian federal prisons

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Type 2 hybrid implementation trial uses a stepped-wedge design to introduce the NIATx implementation strategy bundle across nine federal prisons over a 24-month period, followed by a 12-month sustainability assessment. Prisons were non-randomly allocated to three groups that receive the intervention at staggered six-month intervals. The trial will identify barriers and facilitators to Prison Needle Exchange Program (PNEP) uptake and apply evidence-based implementation strategies to increase engagement. Five of the participating sites are women's prisons, reflecting higher reported histories of injection drug use in those facilities.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All people incarcerated at a study site during the intervention period

Exclusion Criteria:

\- None (site level intervention)

Where it's running

• Dorchester Medium
  Dorchester, New Brunswick, Canada Recruiting
• Atlantic Institution
  Smiths Crossing, New Brunswick, Canada Recruiting
• Nova Institution for Women
  Truro, Nova Scotia, Canada Recruiting
• Edmonton Institution for Women
  Edmonton, Alberta, Canada Not yet recruiting
• Fraser Valley Institution for Women
  Abbotsford British Columbia, British Columbia, Canada Not yet recruiting
• Mission Institution
  Mission, British Columbia, Canada Not yet recruiting

Study contacts

• Principal investigator: Nadine Kronfli — Research Institute of the McGill University Health Centre
• Study coordinator: Nadine Kronfli
• Email: nadine.kronfli@mcgill.ca
• Phone: 514-934-1934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

• Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV

  This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.

  Recruiting Tourcoing Hospital · Tourcoing · NCT07745530

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.